Skip to main navigation Skip to search Skip to main content

Amsacrine treatment of patients with supraventricular arrhythmias and acute leukemia

  • Zalmen Arlin
  • , Rakesh Mehta
  • , Eric Feldman
  • , Phyllis Sullivan
  • , Anthony Pucillo

Research output: Contribution to journalArticlepeer-review

Abstract

Three patients with a history of supraventricular arrhythmia presented with relapse of acute leukemia. Two of the three patients were in sinus rhythm, receiving digoxin and/or verapamil daily. The third patient was in atrial fibrillation, but her heart rate was controlled with daily digoxin. All three patients received amsacrine without the occurrence of cardiac events. Although amsacrine may cause ventricular arrhythmias in the setting of hypokalemia, correction of the electrolyte abnormality permits its use in patients with a history of supraventricular arrhythmias.

Original languageEnglish (US)
Pages (from-to)163-164
Number of pages2
JournalCancer Chemotherapy and Pharmacology
Volume19
Issue number2
DOIs
StatePublished - Apr 1987
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Oncology
  • Toxicology
  • Pharmacology
  • Cancer Research
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Amsacrine treatment of patients with supraventricular arrhythmias and acute leukemia'. Together they form a unique fingerprint.

Cite this